𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The long-term safety and efficacy of gabapentin (Neurontin®) as add-on therapy in drug-resistant partial epilepsy

Book ID
108022870
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
660 KB
Volume
18
Category
Article
ISSN
0920-1211

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety evaluation of lorecl
Efficacy and safety evaluation of loreclezole as add-on treatment in therapy-resistant epilepsy patients
✍ T Rentmeester; J Hulsman 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 381 KB

Thirteen drug-resistant epilepsy patients received loreclezole as add-on therapy. The trial lasted 6 months. Loreclezole was dosed to reach a target plasma concentration between 1 and 3 mg/l. The seizure frequency in the total group decreased by 23%. A reduction of 50% or more was observed in four p

Long-term evaluation of the efficacy and
Long-term evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures: a 1-year open follow-up
✍ T. Rentmeester; A. Janssen; J. Hulsman; F. Scholtes; B. van der Kleij; J. Overwe 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 534 KB

The effect and safety of loreclezole were evaluated during a long-term follow-up trial targeting higher plasma concentrations than those of the preceding controlled trial. The result is better than in the double-blind trial, in which loreclezole doses were administered to reach plasma concentrations